Professional Documents
Culture Documents
Department of Health & Human Services
Department of Health & Human Services
June 3, 2016
Re: K153719
Trade/Device Name: LifeStream™ 5
Regulation Number: 21 CFR 870.2910
Regulation Name: Radiofrequency Physiological Signal Transmitter and Receiver
Regulatory Class: Class II
Product Code: DRG
Dated: April 28, 2016
Received: May 2, 2016
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. Please note: CDRH does not evaluate information related to contract liability
warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA),
it may be subject to additional controls. Existing major regulations affecting your device can be
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act's requirements, including, but not limited to: registration and listing (21 CFR
Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product
radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Page 2 - John Ziobro
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041
or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note
the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21
CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office
of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the
Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301)
796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,,
Shawn W. Forrest -S
2016.06.03 10:52:43 -04'00'
for Bram D. Zuckerman, M.D.
Director
Division of Cardiovascular Devices
Office of Device Evaluation
Center for Devices and Radiological Health
' ( ) * + , - ( . , / 0 1 ( * 2 , 1 * . ' 1 3 - * . 4 ( + 5 6 7 ( 4
S T U V W X X U T Y Z [ \ ] ^ _ ` T a b c d b e b d f b
g h i j k l m j n o p l m q r s l o t l k u v w x y z w {
F G H I J K L I M G N O M P Q N R
| } } ~ | } } }
¡ ¢ £
¤ ¥ ¦ § ¨ ¥ © ª « ¥
¬ ® ¯ ° ± ² ¯ ³ ´ µ ¶
· ¸ ¹ º » ¼ ½ º ¾ ¸ ¿ À ¾ Á Â ¿ Ã Ä Å Æ Ç È É Ê Ë Æ Ì
Í Î Ï Ð Ñ Ò Ó Ð Ô Õ Ö Î × Ô × Ò Ô Ø Ù Ô Ú Û Ø Ð Ü Ý Ó Ð × Þ Ó Î Ý Ò Î Û Ø ß à Ô × Ð Ù × Û Ï Ò á Ô Ó Ð Ý Ó Û â Ó Ô Õ Ù Ð × Î â Ø Ð Ù Ò Û Û Ý Ð Ó Ô Ò Ð Î Ø Ô Þ Ú Î Ø Î Þ Ô Ú × Ð Ò Ò Î Ø â à ã ä Ð Ô Ú Ò ä Þ Ô Ó Ð
å æ ç è é ê ê ë ç ì í î ê ï ð ñ ò ç ì ê ë ê ñ ê ç è í ó ç ê ñ é ô õ é ö ê é æ ÷ é æ ø í ó ç ê ñ é ô ô í ñ í ö í ê é ê é æ ÷ é æ í ì ô ñ õ ç ñ ù å é ê ç è ò î ë é ì ñ ë ì ñ é æ è í ò é ê ú ç ì é ñ ó í ñ ë ê
û ü ý þ ÿ ÿ ý ÿ
ý
ÿ û ü ý þ ÿ ÿ
ÿ
ü
& ' ( ) * ' + + ) * ) , - . / 0 + ) * ) 1 2 / ( . + ' 3 4 ) * 1 ' 2 * 5 ( 6 6 + 4 & ' 3 3 . & ' 7 8 9 : ; < = 6 > ? @ ' 2 3 ) * . & ) * 1 6 2 7 - 4 A B < = C ' 1 @ 0 * = 5 ( 6 6 + @ ( . / 6 3 ' =
D E F G E H I D J H E K L M N G E O N E L F E L M P M O E K Q R S K G E I T U V W X K G H W D Y H W F Z M O D M F E I O L H E D H W N G E P D M [ E \ Q ] ^ F E N N I _ E N `
a b c d e f g d h i g d f g j k l d m f b n d o p q b k l o h p k f r d q h f h s t k d g u q d c b v d q q h f h h o d g f k h v q k p k f d i h o d g f k c j g g d n b d w h v q b v f d g l g d f h f b j v x p h
y z { | } y ~ { z z { | z } z { } } z z z z z ~ z z { | } z }
¡ ¢ £ ¤ £ ¥ ¥ ¦ £ §
¨ © ª « ¬ © ® ¯ ° ± ² « ª ³ ¨ ´ © ¯ µ ¶ · ¸ ¹ º » ¶ ¼ ½ ¾ ® ´ © ¯ ¿ À Á Â Ã Ä Å Æ Ç Ã Å È É Ê Ë Ì Ã Ä Í Î Ã Ï Ð Ñ È Ò Ó Ô Õ Ñ Ö Ê × Ø Ù Ä Ì È Ú
Û Ü Ý Þ ß Ý à á Ü Ý â ã á ä â å â Þ á ä â æ á ß ç Ý á á è á è é
ê ë ì í í î ï ð ì ñ ò ó ô ô õ ì î í ñ ò õ ö ð ñ ÷ î ø ù ì ÷ î ú î ò ð í ñ û ð ë î ü ó ô î ÷ ý ñ ÷ þ ÿ î ù ï ð ì ñ ò ï ð ñ û
! " # $ % & ' # $ ( ) ' * * ) # $ ' " ' & $ " & ' % + # $ ' " $ ( ( # $ % + # ! # ' + , + - . / ' ( 0 ( 0 ' " ( 1 $ " ) * ! $ " - #
F G H I J K L J M N O J P Q R R J P N L Q G Q S L G S Q I T F N L Q G U V J G H P Q T T J G N W I J X F I H L G X N O L W Y Z I H J G J W N L T F N J Q I F G [ Q N O J I F W \ J P N
] ^ _ ` a b a c ^ ] d e f _ a ] c g ] h h i g _ a ] c j a c g h k l a c m b k m m i b _ a ] c b ^ ] d d i l k g a c m _ ` a b n k d l i c j _ ] o
p q r s t u v q w u x y z q s { u | s w } z ~ v s w q t q
¡ ¢ £ ¤ ¥ ¦ ¤ § ¨ £ © ª « ¬ ¦ ® ¯ « ¬ ° ¨ ¯ ± ² ¬ ¡ ³ ³
´ µ ¶ · ¸ ¹ º º » º ¼ ¹ ½ ¾ ¾ ¿ ½ À Á Â
Ã Ä Å Æ Ç È Å É Ê Ë Æ Ê Å Ì Í É Ì Å Î Ï É Í Ì Ð Ñ Ò Ì Å Ñ Ì Ð Ó Æ Å Î Æ Ò È Ð Ñ Ì Å Ô Ñ Å Ì Í Ð È Õ Ï Ô Ð È Î Í Ì Ð È Ñ Ò Ì Å Î Í Ì Ó Æ É Ì Ö Ö È É Í Ô Ì Å Ì ×
Ø Ù Ú Û Ü Ý Þ ß Ø Û Ù à Ù á â ã ã Ø ß ä Ø ã å á Þ æ ã Þ ç à Ü Ü â Ù ß á æ è Þ á Ø ä é ê ë Ù à Ý ì â Ü í î
Page 1 of 1
! ! " # $ ! % &
Honeywell HomMed, LLC
LifeStream software’s intended use is to retrospectively receive, display and store monitored vital signs parameters and
related data. Such data includes patient blood pressure (NIBP), oxygen saturation (SpO2), weight, blood glucose,
temperature, dispensed medicine, ECG, peak flow, prothrombin time and retrospective PERS messages.
LifeStream retrospectively displays the data, user-defined data alerts and system alerts for review and interpretation by a
healthcare professional. LifeStream is not intended for emergency use or real-time monitoring.
Classification Information:
Predicate Device(s): Central Station, Version 4.0, K072272, branded as the LifeStream™ 4.0.
Device Description:
LifeStream 5 is a stand alone, prescription-based software program designed to operate in a clinical setting by healthcare
professionals. It consists of a hosted web server, a hosted database server and two types of client interfaces, one that is
provided by Windows client and one that is provided by a web client interface. LifeStream 5, like the predicate LifeStream
4.0, is configured to accept patient data that is acquired periodically and displayed retrospectively from Honeywell HomMed
Patient Monitors (e.g. Genesis DM, Genesis Touch). LifeStream 5 can also interface with 3rd party compatible medical
device data systems (e.g. Govsphere Tablet, Govsphere TV). LifeStream 5 has the same intended use as the predicate,
LifeStream 4.0. LifeStream 5, like LifeStream 4.0 is not intended for emergency use or real-time monitoring. Both are
designed to retrospectively receive, display and store scheduled vital sign parameters and related data. Such data includes
patient blood pressure (NIBP), oxygen saturation (SpO2), weight, blood glucose, temperature, dispensed medicine, ECG,
peak flow, prothrombin time and retrospective PERS messages.
Technological Characteristics
Both the subject device and predicate device are software programs” with substantially equivalent intended uses, users, and
use environments that were written in C# that operate on PCs powered by AC Mains / battery power.
Programming C# C#
Language
Communications into LifeStream Database Server from the Patient Monitoring System
Transmission POTS, Internet, SkyTel, PageNet POTS, Internet
Output Devices Fax, Printer, email Fax, Printer, email
Communications out of LifeStream Database Server to the Patient Monitoring System
User Interface LifeStream Windows Client LifeStream Windows Client and LifeStream Web Client
Data Integrity & Encrypted in transit and storage. The encryption protocol is Encrypted in transit and storage. The encryption protocol is a
Protection a function of the Patient Monitoring system. The data function of the Patient Monitoring system. The data integrity is
integrity is included as part of the encryption algorithm. included as part of the encryption algorithm. Data hosting
Data hosting database is firewall and antivirus protected. database is firewall and antivirus protected.
HIPAA Yes Yes
Compliant
Conclusions:
Honeywell HomMed, LLC, believes the proposed LifeStream 5 device under review and the predicate device (LifeStream 4)
are substantially equivalent in their intended use, intended users, intended use environment and indications for use.
Furthermore, both systems have the same/equivalent technological characteristics, physical characteristics, labeling and
safety standards. The differences that exist between the devices, relating to the ability to access the software program via the
web (rather than just via Windows, the addition of Honeywell defined disease management protocols and the ability to
interface with 510(k) exempt third-party MDDS systems do not affect the relative safety and/or effectiveness